Learn more

ANTIBIOTICOS SAU

Overview
  • Total Patents
    47
About

ANTIBIOTICOS SAU has a total of 47 patent applications. Its first patent ever was published in 1997. It filed its patents most often in Spain, WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets biotechnology, foods and drinks and basic materials chemistry are GENOFOCUS CO LTD, SYNTHETIC GENOMICS INC and INBIOSE N V.

Patent filings per year

Chart showing ANTIBIOTICOS SAUs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Diez Garcia Bruno 28
#2 Barredo Fuente Jose Luis 22
#3 Rodriguez Saiz Marta 15
#4 Marcos Rodriguez Ana Teresa 11
#5 Salto Maldonado Francisco 9
#6 Mellado Duran Encarnacion 8
#7 Velasco Alvarez Javier 8
#8 Cabri Walter 8
#9 Costa Perez Javier 8
#10 Moreno Valle Miguel Angel 8

Latest patents

Publication Filing date Title
WO2006053929A1 Method of producing the penicillin v acylase enzyme from streptomyces lavendulae in recombinant micro-organisms
ES2203315A1 ASTAXANTINE PRODUCTION PROCEDURE THROUGH THE FERMENTATION OF SELECTED VINTAGES OF XANTHOPHYLLOMYCES DENDRORHOUS.
ES2195766A1 BETA-CAROTENE PRODUCTION PROCEDURE FOR FERMENTATION IN MIXED CULTURE USING BLAPESLEA TRISPORA (+) 4 (-).
ES2195758A1 IMPROVED LICOPENO PRODUCTION PROCEDURE THROUGH THE FERMENTATION OF SELECTED BLISES OF BLAKESLEA TRISPORA, FORMULATIONS AND USES OF THE LICOPENO OBTAINED.
ES2189697A1 PROCEDURE FOR OBTAINING NEW FORMULATIONS BASED ON LUTEINE.
ES2168971A1 BETA-CAROTENE PRODUCTION PROCEDURE.
ES2167182A1 PROCEDURE FOR INCREASING THE PRODUCTION OF BETA-LACTAMIC ANTIBIOTICS IN FILAMENTARY FUNGES THROUGH THE EXPRESSION OF THE CODIFYING GENE FOR CISTATIONINA-GAMMA-LIASA.
ES2157166A1 PROCEDURE FOR OBTAINING LICOPEN.
ES2165276A1 BIOTECHNOLOGICAL PROCEDURE FOR THE PRODUCTION OF OSPORANIC 7-AMINOCEPHAL ACID (7-ADCA) AND PARTICULARLY INTERMEDIATE SYNTHESIS COMPOUNDS PENICILLIN N AND DEACETOXYCHEFALOSPORINE C (DAOC)
ES2156735A1 LICOPENO PRODUCTION PROCEDURE.
ES2187219A1 IMPROVEMENT OF STREPTOMYCES STRAINES BY USING CLAVULANIC ACID BIOSINTETIC GENES.
ES2156812A1 AN EXTRACELLULAR PROTEASE OF ACREMONIUM CHRYSOGENUM WITH CPC-ACETILHIDROLASA ACTIVITY AND ITS USE FOR THE SYNTHESIS OF DEACTILATED DERIVATIVES OF CEPHALOSPORIN C AND INACTIVATION OF THE GENE TO INCREASE THE PRODUCTION OF CEPHALOSPORIN.
ES2155342A1 IMPROVEMENTS OF STREPTOMYCES STRAPS THROUGH THE USE OF BIOSYNTHETIC GENES OF TILOSINA.
ES2131018A1 AN ENZYMATIC PROCEDURE FOR PREPARING 7BETA- (4-CARBOXYBUTANAMIDE) CEPHALOSPORANIC ACID USING THE MODIFIED TRIGONOPSIS VARIABILIS ENZYME D-AMINO ACID PRODUCED IN ESCHERICHIA COLI.
ES2133104A1 A PROCEDURE TO INCREASE THE PRODUCTION OF PENICILLIN IN PENICILLIUM CHRYSOGENUM BY INACTIVATING THE LYS2 GENE.
ES2131001A1 PROCEDURE TO INCREASE THE PRODUCTION OF CLAVULANIC ACID THROUGH THE EXPRESSION OF REGULATORY AND BIOSYNTHETIC GENES OF STREPTOMYCES CLAVULIGERUS.
ES2127697A1 PROMOTERS OF THE GENES GLUTAMATE DEHYDROGENASE, BETA-N-ACETYLHEXOSAMINIDASE AND GAMMA-ACTIN AND THEIR USE IN EXPRESSION, SECRETION AND ANTI-SENSE SYSTEMS OF FILAMENTARY FUNGI.